Chemical and biological properties of nordihydroguaiaretic acid

Abstract

Nordihydroguaiaretic acid (NDGA) is a natural product obtained by the alkaline extraction of dried plants of Larrea tridentata species. Due to the biological properties presented, such as antioxidant, anti-inflammatory, antiviral and cytotoxic capacity, this compound is being increasingly studied. In this review, it was evaluated the benefits of NDGA against different animal models. Besides that, it was found that this compound has antitumor activity similar to its synthetic derivative terameprocol in prostate tumors. The hypoglycemic effect may be evidenced by the inhibition of sugar uptake by NDGA; in obesity, studies have observed that NDGA presented a positive regulatory effect for Peroxisome proliferator-activated receptors (PPAR-α) involved in the oxidation of hepatic fatty acids and reduced the expression of lipogenic genes. Regarding its antioxidant potential, its mechanism is related to the ability to in vitro scavenging reactive substances. Although there are several studies demonstrating the benefits of using NDGA, there are also reports of its toxicity, mainly of liver damage and nephrotoxicity.

Keywords:
Chaparral; Clinical applications; NDGA; Toxicity

INTRODUCTION

Nordihydroguaiaretic acid (NDGA) is a natural product obtained by extraction of dried plants of Larrea tridentate species (Arteaga, Andrade-cetto, Cárdenas, 2005), popularly known as “chaparral” (Hyder et al., 2002). It has been used in the USA since the 1940 as an antioxidant compound for stabilization of oils and edible fats (Billinsky, Krol, 2008).

NDGA is one of the main metabolites present in L. tridentata, representing 80% of the phenolic compounds found in the resin that recovers its leaves (Hernández-Damián, Andérica-Romero, Pedraza-Chaverri, 2014). In addition to NDGA, these resins have flavonoids, essential oils and other phenols, which act as antimicrobial agents and radiation protection (Konno et al., 1990).

The biological activity of NDGA was assessed through in vitro and in vivo studies where NDGA was effective in treating various diseases, such as cancer, diabetes, and obesity, among others (Leon et al., 2016; Lü et al., 2010; Paracatu et al., 2015; Stadtman, 1993; Youngren et al., 2005; Zhang et al., 2016). It was approved in the USA for topical use in treatment of actinic keratosis (Billinsky, Krol, 2008). In addition, Masoprocol, that is the generic name of NDGA, demonstrated promising activity as a new antineoplastic agent for topical use (Li et al., 2013; Olsen et al., 1991).

Although the NDGA has several biological activities, its use for therapeutic purposes is limited due to reports of toxicity, such as nephrotoxicity (Grice et al., 1968), hypersensitivity contact (Olsen et al., 1991), hepatotoxicity and cytotoxicity (Lambert et al., 2002; Lü et al, 2010).

This review aims to describe the general properties of NDGA, as well as to summarize some of its biological activities, demonstrating its potential for medical use, based on in vitro and in vivo studies found in the literature, as well as discussing its possible toxicity.

General properties of NDGA

The NDGA is the main metabolite extracted from the resin of the leaf of the creosote shrub, L. tridentata, abundant in desert areas of Mexican states (Arteaga, Andrade-cetto, Cárdenas, 2005). It belongs to the lignin family, whose chemical structure is classified as an o-dihydroxy (catechol), presenting four phenolic hydroxyl groups (Figure 1A) (Floriano-Sánchez et al., 2006).

FIGURE 1
Chemical structure of: A) Nordihydroguaiaretic acid (NDGA); B) Terameprocol; C) Nordihydroguaiaretic tetra-O-methyl acid (M4N).

NDGA is recognized as an antioxidant compound, presenting several beneficial biological effects for health, such as, cytotoxic (Rowe et al., 2008), anti-viral (Merino-Ramos et al., 2017), antioxidant (Sheikh, Philen, Love, 1997) and anti-inflammatory (Sifre et al., 1993).

It is described that hydrophobicity is a very important factor for the pharmacological action and toxicological effect of chemical compounds (Cronin, 2006), because this characteristic affects the absorption, bioavailability and interactions with the hydrophobic receptor. NDGA is a hydrophobic compound, presenting a Log p = 4.48 (Paracatu et al., 2015).

In relation to the pharmacokinetics of this compound at a single dose of 50 mg kg^-1 intravenously, the maximum plasma concentration is 14.7 mg ml^-1 in rats (Lambert et al., 2001). In addition, approximately 99.8% of the NDGA present in plasma is protein bound, with a half-life distribution of 30 minutes, a terminal half-life of 135 minutes and renal clearance of 201.9 mL min^-1 kg^-1. These results demonstrate that in addition to its hydrophobicity, its high degree of protein binding limits the in vivo bioavailability of NDGA, and the considerably high half-life may render the cytotoxic compound due to possible tissue accumulation (Lambert, Dorr, Timmermann, 2004).

Biological activity

The biological potential of NDGA has been widely studied. When related to diseases in animal models, it is observed that the mechanisms of action of NDGA are varied (Table I).

TABLE I
Mechanism used by NDGA in different studies

Type of study	Mechanism of action	Authors
In vivo	Upregulating PPAR-α protein	Chan et al., 2018
In vitro	Inhibition of lipoxygenase	Bibikova et al., 2017
In vivo	Spermatogenesis and antioxidant	Abbas, Badran, Disi, 2018
In vitro	Inhibition of viral replication	Merino-Ramos et al., 2017
In vivo	Anti-anaphylactic action	Bergren,Valentine, 2016
In vitro	GLUT-1 Inhibitor	Leon et al., 2016
In vivo/In vitro	Chemopreventive potential / Synergism	Kimura, Huang, 2016
In vivo/In vitro	Synergism with antibiotics	Cunningham-Oakes et al., 2015
In vitro	Melanogenesis in human melanoma cells	Takekoshi, Nagata, Kitatani, 2014
In vitro	Inhibition of the G1 phase of the cell cycle	Gao et al., 2011
		Cui et al., 2008

• PPAR-α (Peroxisome proliferator-activated receptors); GLUT-1 (glucose transporter 1).

There are a large number of studies assessing the chemopreventive potential (Kimura, Huang, 2016; Yarla et al., 2016), antioxidant (Fujimoto et al., 2004) and as a selective 5-LOX inhibitor (West et al., 2004). Thus, it was observed that the versatility of NDGA allows its application in several lines of research (Figure 2) (Bergren, Valentine, 2016; Kriska et al., 2012).

FIGURE 2
Effects and biological activities of NDGA.

Antitumor effect

For the antitumor purposes, both NDGA and its synthetic derivative terameprocol (Figure 1B) present satisfactory results in cases of prostate tumors (Ryan et al., 2008), breast cancer (Youngren et al., 2005), melanoma (Lambert et al., 2001) and neuroblastoma (Meyer et al., 2007). In melanoma cells (malignant tumor originating from melanocytes, which are cells that produce pigment), NDGA increased the amount of intracellular melanin and the activity of tyrosinase, an enzyme responsible for production of melanin in HMVII cells (human vaginal epithelial cells) (Takekoshi, Nagata, Kitatani, 2014).

The antitumor mechanism of NDGA action is not exactly known, however, some studies have presented some mechanisms. It is known that most cells need glucose catabolism to produce energy. In this sense, the relationship between glucose uptake by cells and NDGA was evaluated. The results demonstrated that NDGA was able to inhibit and interact with the GLUT-1 (glucose transporter 1) transporter in leukemic cell lines HL-60 and U937 (Leon et al., 2016).

In tumors, normally a cell cycle disorder is observed, especially at the checkpoints that occur between the G1 and S phases (Cui et al., 2008). When analyzing SiHa cells from cervical cancer, NDGA has been shown to induce cell cycle arrest in G1 phase, resulting in inhibition of HPV-16 E6 expression in a dose-dependent manner (Culver et al., 2005; Gao et al., 2011).

Bibikova et al. (2017) evaluated the ability of NDGA and Lecanicillum lecanii extract to induce cell death. Using P388 leukemic cell cultures, it was possible to observe that both compounds induced the cells to apoptosis. An increase of cells in the SubG1 phase was observed, presenting fragmented deoxyribonucleic acid (DNA) in a dose-dependent manner. Seufferlein et al. (2002) observed a similar effect regarding apoptosis. The authors concluded that NDGA induces cell death due to disruption of the actin cytoskeleton and activation of protein kinases.

Hypoglycemic effect

Considered as a metabolic disorder, diabetes mellitus is responsible for causing hyperglycemia as a consequence of the destruction of pancreatic β-cells or the development of resistance to insulin action in the body (American Diabetes Association, 2010).

Dain et al. (2016) evaluated the potential of NDGA in decreasing glucose levels, there is the study of In this study, mice were induced to diabetes by the administration of fatty acid once a month at the concentration of 6.25 mg kg^-1 for 12 months and received intraperitoneally treatment of 1.9 mg kg^-1 NDGA once a month for the same period. They found that the treatment with NDGA resulted in a decrease in glycemic levels following oral glucose tolerance and glycated hemoglobin tests. The tests were performed on day 40 and at the end of the sixth and tenth month of treatment. The possible mechanism of NDGA action against diabetes is through the glucose transporter 1 (GLUT1) receptor, responsible for controlling the entry of glucose into cells.

Using the glucose uptake and glucose monitoring in human erythrocytes, where the GLUT1 plays the role of the main transporter, the data presented suggest that NDGA competes with D-glucose to bind to the GLUT1 receptor (Leon et al., 2016).

It also stands out the inhibitory effect of NDGA on the α-glucosidase, α-amylase and dipeptidyl peptidase 4 enzymes, thus suggesting a possible mechanism for its use as an antidiabetic compound (Roskar, Strukelj, Lunder, 2016).

Effect on metabolism and obesity

Obesity is a physical condition that becomes increasingly common, especially in American individuals, due to dietary habits based on soft drinks and extremely caloric foods associated with lack of physical exercise (Seidell, Halberstadt, 2016).

In a study where the mice were induced to obesity through the American Lifestyle Induced Obesity Syndrome (ALIOS) diet, which consists of a high fat modified diet, accompanied by drinking water supplemented with high fructose corn syrup. The mice were divided into 3 groups: a group that received only standard feed; another received only the ALIOS diet; and finally a group that received the ALIOS diet plus the treatment with NDGA, 2.5 g kg^-1. The experiment lasted 8 weeks. They found that rats that consumed only the ALIOS diet developed obesity, metabolic imbalances, including hepatic steatosis with liver damage, dyslipidemia, insulin resistance and glucose intolerance, and exhibited increased expression of key enzymes of genes involved in liver lipogenesis. On the other hand, animals fed with ALIOS diet supplemented with NDGA presented a positive regulatory effect for peroxisome proliferator-activated receptors (PPAR-α) involved in the oxidation of hepatic fatty acids and reduced the expression of lipogenic genes, also showed increased expression of antioxidant enzymes (Chan et al., 2018).

With the objective of examining the effects of NDGA dietary administration on the gene expression involved in lipid homeostasis in the liver, skeletal muscle and adipose tissue, Zhan et al. (2016) fed rats with a 60% fructose diet supplemented with 2.5 g kg^-1 NDGA for 16 weeks. The results showed that chronic dietary treatment with NDGA could attenuate hypertriglyceridemia induced by a diet rich in fructose and hepatic steatosis (accumulation of thyroglobulin). In addition, the analysis indicated that NDGA increases the expression of enzymes involved in the oxidation of liver fatty acids and proteins that facilitate the transport of fatty acids. Based on the experimental data, the authors concluded that the beneficial effects of NDGA in triglycerides and steatosis are carried by inhibiting lipogenesis, and increasing the functional expression of key genes for enzymes/ proteins involved in the pathway of β-oxidation of fatty acids in liver and skeletal muscle, which corroborates the previously described study.

Synergism with antimicrobials

There is great difficulty in treating infections caused by methicillin-resistant Staphylococcus aureus (MRSA) (Fry, Barie, 2011). The NDGA shows antimicrobial activity, with possible action on the bacterial membrane. The NDGA among with the antibiotics gentamicin, neomycin and tolbramycin, were tested in isolates of MRSA and methicillin sensitive S. aureus (MSSA). The results demonstrated that NDGA could alter membrane permeability in bacteria, potentiating the response to antimicrobial agents in vitro and allowing a combination of antibiotic accumulation at the target site (Cunningham-Oakes et al., 2015).

In a study by Ohene-Agyei et al. (2014), the ability of natural products to increase the microbial activity of antibiotics was evaluated. NDGA had a synergistic relationship with known antibiotics, for example, erythromycin, chloramphenicol and tetracycline. The result of this union was satisfactory because the time in which the bacteria was exposed to the drug increased. As demonstrated, the NDGA is able to act on the efflux pumps present in the bacterial cells, altering their activity and consequently decreasing the drug’s output from the cell.

Antioxidant activity

Antioxidants are compounds that inhibit the formation of free radicals or prevent the stage of propagation of these reactions, through the donation of hydrogen, such that the target molecule becomes stable, acting in delaying or preventing oxidation (Broinizi et al., 2007; Soares, 2002).

Naturally, the metabolism of oxygen generates a significant amount of reactive species. The hydroxyl radical, which can be formed through different reactions, is considered one of the most reactive radical species due to the potential damage caused in DNA and proteins, characterizing the so-called oxidative stress (Boyd, Mcguire, 1991; Hájková, Barek, Vysko, 2017; Stadtman, 1993).

The use of natural antioxidant compounds has gained importance due to the low toxicity to the organism (Moure et al., 2001). NDGA is a natural compound that has considerable antioxidant properties, and has been used for a long time in folk medicine (Arteaga, Andrade- cetto, Cárdenas, 2005). Its potential is related to the ability to sequester reactive species in vitro such as peroxynitrite, singlet oxygen, hydroxyl radical and superoxide anion, decreasing the probability of developing diseases involved with oxidative stress processes, such as cancer (Floriano-Sánchez et al., 2006).

The antioxidant capacity of a compound is a great pharmaceutical interest. Considering this question, Huang et al. (2017) evaluated the potential of NDGA in an animal model of induced transient ischemia.

Through intracerebroventricular injection, the animals received a concentration of 0.2 mg kg^-1 of 2,5-bis (3,4-dihydroxybenzylidene) cyclopentanone, which is an analog of NDGA, while another group received edavarone, a standard drug. The NDGA analogue evaluated showed satisfactory results. In addition to the reduction of the infarct region, as a consequence of the ischemic episode, the antioxidant potential can also be confirmed in the pre-treated rats, making the NDGA very promising in the treatment of stroke (Candelario-Jalil, 2009).

Anti-anaphylactic effect

An anaphylactic shock occurs when the immune system develops a severe hypersensitivity reaction to a substance considered as an allergen to the body resulting in airway problems and the release of inflammatory mediators (Kastner, Harada, Waserman, 2010; Sampson et al., 2006; Simons et al., 2011).

NDGA has several interesting properties for the research, such as its antioxidant effect, arterial hypertension antagonist and lipoxygenase inhibitor (5-LOX), which aroused the interest of the possible application of this compound in cases of anaphylactic shock (Kriska et al., 2012; Shen et al., 2015).

The anti-anaphylactic potential of NDGA was evaluated in an animal model using guinea-pigs sensitive to ovalbumin. The efficacy of the compound was evaluated by the quantification of leukotrienes 4 (LT4), where the groups previously treated both intravenously and through aerosols presenting lower levels of LT4. The possible mechanism used by the NDGA, according to the study, occurs through 5-lipoxygenase blockade, which consequently inhibits the synthesis of leukotrienes, which are involved in bronchoconstriction (Bergren, Valentine, 2016).

Antiviral effect

Viruses are considered obligatory intracellular parasites due to their characteristic of using the machinery and resources of a host cell, so they can multiply and infect other cells (Chan, Gack, 2016).

In antiviral studies, NDGA was able to inhibit the multiplication of viruses such as dengue (Soto-Acosta et al., 2014). Recently, NDGA and its methylated derivative nordihydroguaiaretic tetra-O-methyl acid (M4N) (Figure 1C) were evaluated in a model using West Nile flavivirus (WNV) and Zika virus, responsible for causing meningitis and encephalitis and congenital anomalies, respectively. The obtained results demonstrated that both compounds can inhibit viral replication. It is believed that the inhibition is related to the metabolic alterations of the cells that prevent the replication of the viruses, which present obligate intracellular parasite conditions (Merino-Ramos et al., 2017).

Potential anti-aging

Publications related to aging are increasing and can provide important information to deal with this implication (Kerschner, Pegues, 1998).

In order to evaluate agents that aim to increase life expectancy and postpone the onset of diseases, NDGA has been shown to prolong the life span of mice, as well as delay several age-related health problems (Strong et al., 2008). The same effect can be observed in experiments with Drosophila melanogaster (Drosophila). The responses presented different aspects in flies and mice. However, NDGA has demonstrated that it can prolong the life span of mice and Drosophila, suggesting that its performance can be conserved phylogenetically (Spindler et al., 2015).

Toxicity

The NDGA is the active compound present in the Chaparral plant (Arteaga, Andrade-cetto, Cárdenas, 2005). Studies have indicated cases of hepatotoxicity in patients who received chaparral, and cases of liver damage after chronic ingestion of chaparral (Grant, Boyer, Erdman, 1998). Sheikh, Philen, Love (1997) concluded that the use of chaparral may be associated with acute irreversible liver damage with chronic fulminant hepatic failure.

In a model of in vitro rat hepatocyte cultures aimed to evaluate the hepatological and pro-oxidant potential of NDGA, it was observed that the compound exerts adverse prooxidant effects on hepatocyte cultures, but showed beneficial antioxidant activity in macrophages, thus suggesting that the NDGA has a potential to act as a pro- and antioxidant depending on its concentration (Sahu, Ruggles, O’Donnell, 2006).

Acute exposure to NDGA, depending on the dose, results in lethality in mice. The toxicity of NDGA is marked by elevation in serum levels of the enzyme alanine aminotransferase. Although mouse hepatocytes are more sensitive to NDGA-induced cytotoxicity than human melanoma cells, these findings aim to reduce the parenteral administration of NDGA, without excluding its use in topical formulations (Lambert et al., 2002).

Even the liver being the main metabolizing organ of xenobiotics (De Carvalho et al., 2013), it was demonstrated that NDGA can cause cystic nephropathy in rats. Its occur due to the quinone resulting from the metabolism process of NDGA absorbed by the proximal tubular epithelium and accumulate in the lysosomes, thus leading to the destruction of tubular epithelial cells and tubule blockage (Goodman et al. 1970; Evan, Gardner, 1979) (Figure 3).

FIGURE 3
Renal cell death caused by NDGA.

Lambert et al. (2002) have shown that the NDGA nephrotoxicity can be brought about by methylation of the hydroxyl groups of catechol. In the literature it is also found that NDGA is used as a model of induction by renal disease drug (Evan, Gardner, 1979; Gardner, Evan, Reed, 1986; Goodman et al. 1970).

In view of the clinical evidence of hepatotoxicity and nephrotoxicity caused by NDGA ingestion, Spindler et al. (2015) investigated their toxicity and relationship to pathologies leading to mortality. Based on this, they found an association between NDGA consumption and an increased incidence of liver, lung and thymus tumors.

In contrast, Zúñiga-Toalá et al. (2012) evaluated the protective effect of NDGA in renal injuries induced by ischemia and reperfusion (I/ R), oxidative stress and changes in antioxidant enzymes and mitochondrial function in rats. The data obtained by them showed that NDGA protects against damage induced by I/ R, and its protective effect is related to renoprotection, associated with the prevention of oxidative stress. Yam-Canul et al. (2008) studied the effect of NDGA on nephrotoxicity induced by potassium dichromate (K2Cr2O7) and oxidative stress. The results showed that NDGA was able to improve the structure and reduce the damage in renal function evaluated by histopathological and biochemical analysis. The protective effect of NDGA in this study was also associated with improved oxidative stress, suggesting that the antioxidant properties of NDGA are involved in its renoprotective effect.

In addition, NDGA and its derivative terameprocol are recognized for their ability to activate NRF2 transcription factor (erythroid-related nuclear factor 2). This activation is promising for the treatment of several chronic diseases (Robledinos-Antón et al., 2019). It can be explained by the cytoprotective effects of Nrf2, which is the main regulator of genes that encode many antioxidant and detoxifying enzymes. (Aminzadeh et al., 2013)

In concern of the data exposed above, it is possible that the difference between the protective and toxic effects of NDGA may be related to the daily dose administered. The protective effect of NDGA in vivo was observed at 5 to 100 mg/ kg/ day, while toxic effects were observed at doses greater than 1 g/ kg/ day (Gardner, Evan, Reed, 1986; Goodman et al,. 1970; Yam-Canul et al., 2008; Zúñiga-Toalá et al., 2012).

FINAL CONSIDERATIONS

NDGA, the main metabolite present in L. tridentata, besides presenting antioxidant action, has been shown to have promising applications in the treatment of several diseases, such as cardiovascular diseases, neurological disorders and cancers. However, in relation to its safety and toxicity, its clinical application is limited, presenting several reports of nephrotoxicity and hepatotoxicity.

In the literature, many biological activities of NDGA have already been described (Goodman et al., 1994; Guzmán-Beltrán et al., 2016; Lü et al., 2010) its reported benefits are diverse and can aid in the prevention or reduction of clinical manifestations. High-incidence diseases, such as diabetes (Anjaneyulu, Chopra, 2004) and neoplasms (Seufferlein et al., 2002) are the main targets for this compound. When considering all these factors, it becomes clear the importance of more studies involving NDGA, evidencing new benefits. The results may serve as basis for further research, so all the biological properties of the compound can be exploited and applied in therapy.

ACKNOWLEDGMENTS

Authors greatly acknowledge the scholarship from CNPq to D. F. Grigoletto (159815/2018-5).

REFERENCES

• Abbas MA, Badran D, Disi A. Effect of nordihydroguaiaretic acid on spermatogenesis and fertility in rats. Andrologia. 2018;50(3)1-9.
• American diabetes association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2010;33(1):63-9.
• Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant. 2013;28(8):2038-45.
• Anjaneyulu M, Chopra K. Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats. Pharmacology. 2004;72(1):42-50.
• Arteaga S, Andrade-cetto A, Cárdenas R. Larrea tridentata (Creosote bush), an abundant plant of Mexican and US- American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharmacol. 2005;98(3):231-9.
• Bergren DR, Valentine JL. Anti-anaphylactic action of nordihydroguaiaretic acid in antigen sensitized guinea pigs. Respir Physiol Neurobiol. 2016;234:26-31.
• Bibikova MV, Spiridonova NA, Korystova AF, Kublik LN, Levitman MK, Shaposhnikova VV, et al. Lipoxygenase inhibitors nordihydroguaiaretic acid and fungus Lecanicillum lecanii extract induce death of lymphoid leukemia cells. Bull Exp Biol Med. 2017;163(3):330-3.
• Billinsky JL, Krol ES. Nordihydroguaiaretic acid autoxidation produces a schisandrin-like dibenzocyclooctadiene lignan. J Nat Prod. 2008;71(9):1612-15.
• Boyd NF, Mcguire V. The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med. 1991;10(3):185-90.
• Broinizi PRB, Andrade-Wartha ERS, Silva AMO, Novoa AJV, Torres RP, Azeredo HMC, et al. Avaliação da atividade antioxidante dos compostos fenólicos naturalmente presentes em subprodutos do pseudofruto de caju (Anacardium occidentale L). Ciênc Tecnol Aliment. 2007;27(4):902-8.
• Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs. 2009;10(7):644-54.
• Chan JKW, Bittner S, Bittner A, Atwal S, Shen WJ, Inayathullah M, et al. Nordihydroguaiaretic acid, a lignan from Larrea tridentata (creosote bush), protects against american lifestyle-induced obesity syndrome diet- induced metabolic dysfunction in mice. J Pharmacol Exp Ther. 2018;365(2):281-90.
• Chan YK, Gack M. Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol. 2016;14(6):360-73.
• Cronin MTD. The Role of hydrophobicity in toxicity prediction. Cur Comput-AID Drug. 2006;2(4):405-13.
• Cui Y, Lu C, Liu L, Sun D, Yao N, Tan S, et al. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. Life Sci. 2008;82(5-6):247-255.
• Culver CA, Michalowski SM, Maia RC, Laster SM. The anti-apoptotic effects of nordihydroguaiaretic acid: Inhibition of cPLA(2) activation during TNF-induced apoptosis arises from inhibition of calcium signaling. Life Sci. 2005;77(19):2457-70.
• Cunningham-Oakes E, Soren O, Moussa C, Rathor G, Liu Y, Coates A, et al. Nordihydroguaiaretic acid enhances the activities of aminoglycosides against methicillin- sensitive and resistant Staphylococcus aureus in vitro and in vivo Front Microbiol. 2015;6:1-8.
• Dain A, Repossi G, Diaz-Gerevini GT, Vanamala J, Das UM, Eynard AR. Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats). Lipids Health Dis. 2016;15(1):1-15.
• De Carvalho WL, Maiolo MA, Mendes LCN, Rozza DB, Mingatto FE. Mecanismos da intoxicação do fígado de rato causada pelo gossipol. Pesq Vet Bras. 2013;33(3):339-44.
• Evan AP, Gardner KD Jr. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int. 1979;15(1):7-19.
• Floriano-Sánchez E, Villanueva C, Medina-Campos ON, Rocha D, Sánchez-González DJ, Cárdenas-Rodríguez N, et al. Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs. Free Radic Res. 2006;40(5):523-33.
• Fry DE, Barie PS. The Changing Face of Staphylococcus aureus: A continuing surgical challenge. Surg Infect (Larchmt). 2011;12(3):191-203.
• Fujimoto N, Kohta R, Kitamura S, Honda H. Estrogenic activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life Sci. 2004;74(11):1417-25.
• Gao P, Zhai F, Guan L, Zheng J. Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up- regulating p21. Oncol Lett. 2011;2(1):123-28.
• Gardner KD Jr, Evan AP, Reed WP. Accelerated renal cyst development in deconditioned germ-free rats. Kidney Int . 1986; 29(6):1116-23.
• Goodman T, Grice HC, Becking GC, Salem FA. A cystic nephropathy induced by nordihydroguaiaretic acid in the rat. Light and electron microscopic investigations. Lab Invest. 1970;23(1):93-107.
• Goodman Y, Steiner MR, Steiner SM, Mattson MP. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 1994;654(1):171-76.
• Grant KL, Boyer LV, Erdman BE. Chaparral- induced Hepatotoxicity. Int Med. 1998;1(2):83-7.
• Grice HC, Becking G, Goodman T. Toxic properties of nordihydroguaiaretic acid. Food Cosmet Toxicol. 1968;6(2):155-61.
• Guzmán-Beltrán S, Rubio-Badillo MÁ, Juárez E, Hernández-Sánchez F, Torres M. Nordihydroguaiaretic acid (NDGA) and α-mangostin inhibit the growth of Mycobacterium tuberculosis by inducing autophagy. Int Immunopharmacol. 2016;31:149-57.
• Hájková A, Barek J, Vysko V. Bioelectrochemistry electrochemical DNA biosensor for detection of DNA damage induced by hydroxyl radicals. Bioelectrochemistry. 2017;116:1-9.
• Hernández-Damián J, Andérica-Romero AC, Pedraza-Chaverri J. Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid. Arch Pharm (Weinheim). 2014;347(10):685-97.
• Huang L, Wang J, Chen L, Zhu M, Wu S, Chu S, et al. Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents. Eur J Med Chem. 2017;143:1165-73.
• Hyder PW, Fredrickson EL, Estell RE, Tellez M, Gibbens RP. Distribution and concentration of total phenolics, condensed tannins, and nordihydroguaiaretic acid (NDGA) in creosotebush (Larrea tridentata). Biochem Syst Ecol. 2002;30(10):905-12.
• Kastner M, Harada L, Waserman S. Gaps in anaphylaxis management at the level of physicians, patients, and the community : a systematic review of the literature. Allergy. 2010;65(4):435-44.
• Kerschner H, Pegues JA. Productive aging: A quality of life agenda. J Am Diet Assoc. 1998;98(12):1445-48.
• Kimura K, Huang RCC. Tetra-O-methyl nordihydroguaiaretic acidbroadlysuppressescancermetabolismandsynergistically induces strong anticancer activity in combination with etoposide, rapamycin and ucn-01. Plos One. 2016;11(2):1-28.
• Konno C, Lu ZZ, Xue HZ, Erdelmeier CA, Meksuriyen D, Che CT, et al. Furanoid lignans from Larrea tridentata J Nat Prod . 1990;53(2):396-406.
• Kriska T, Cepura C, Magier D, Siangjong L, Gauthier KM, Campbell WB. Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension. Am J Physiol Heart Circ Physiol. 2012;302(11):H2428-H2438.
• Lambert JD, Dorr RT, Timmermann BN. Nordihydroguaiaretic acid: A review of its numerous and varied biological activities. Pharm Biol. 2004;42(2):149-58.
• Lambert JD, Meyers RO, Timmermann BN, Dorr RT. Tetra- O-Methylnordihydroguaiaretic acid inhibits melanoma in vivo Cancer Lett. 2001;171(1):47-56.
• Lambert JD, Zhao D, Meyers RO, Kuester RK, Timmermann BN, Dorr RT. Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon. 2002;40(12):1701-1708.
• Leon D, Parada D, Vargas-Uribe M, Perez AA, Ojeda L, Zambrano A, et al. Effect of nordihydroguaiaretic acid on cell viability and glucose transport in human leukemic cell lines. FEBS Open Bio. 2016;6(10):1000-07.
• Li X, Jiang JH, Chen Q, Xiao SX, Li CH, Gu HW, et al. Synthesis of nordihydroguaiaretic acid derivatives and their bioactivities on S. pombe and K562 cell lines. Eur J Med Chem . 2013;62:605-13.
• Lü JM, Nurko J, Weakley SM, Jiang J, Kougias P, Lin PH, et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010;16(5):RA93-100.
• Merino-Ramos T, Jiménez ON, Saiz JC, Martín-Acebes MA. Antiviral activity of nordihydroguaiaretic acid and its derivative tetra-O-methyl nordihydroguaiaretic acid against West Nile virus and Zika virus. Antimicrob Agents Chemother. 2017;61(8):e00376-17.
• Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, et al. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem. 2007;102(6):1529-41.
• Moure A, Cruz JM, Franco D, Domínguez JM, Sineiro J, Domínguez H, et al. Natural antioxidants from residual sources. Food Chem. 2001;72(2):145-71.
• Ohene-Agyei T, Mowla R, Rahman T, Venter H. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Microbiologyopen. 2014;3(6):885-96.
• Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24(5):738-43
• Paracatu LC, Faria CM, Zeraik ML, Quinello C, Rennó C, Palmeira P, et al. Hydrophobicity and antioxidant activity acting together for the beneficial health properties of nordihydroguaiaretic acid. Food Funct. 2015;6(6):1818-31.
• Robledinos-Antón N, Fernández-Ginés R, Manda G, Cuadrado A. Activators and inhibitors of NRF2: a review of their potential for clinical development. Oxid Med Cell Longev. 2019;2019:9372182:1-20.
• Roskar I, Strukelj B, Lunder M. Screening of phenolic compounds revealsinhibitory activityofnordihydroguaiaretic acid against three enzymes involved in the regulation of blood glucose level. Plant Foods Hum Nutr. 2016;71(1):88-9.
• Rowe DL, Ozbay T, Bender LM, Nahta R. Nordihydroguaiaretic acid, a cytotoxic IGF-IR/HER2 inhibitor in trastuzumab-resistant breast cancer. Mol Cancer Ther. 2008;7(7):1900-08.
• Ryan CJ, Harzstark AH, Rosenberg J, Lin A, Claros C, Goldfine ID, et al. A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer. BJU Int. 2008;101(4):436-39.
• Sahu SC, Ruggles DI, O’Donnell MW. Prooxidant activity and toxicity of nordihydroguaiaretic acid in clone-9 rat hepatocyte cultures. Food Chem Toxicol. 2006;44(10):1751-57.
• Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis : Summary report - Second National Institute of Allergy and Infectious Disease / Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-97.
• Seidell JC, Halberstadt J. Obesity: The obesity epidemic in the USA-NO end in sight? Nat Rev Endocrinol. 2016;12(9):499-500.
• Seufferlein T, Seckl MJ, Schwarz E, Beil M, Wichert G, Baust H, et al. Mechanisms of nordihydroguaiaretic acid- induced growth inhibition and apoptosis in human cancer cells. Br J Cancer. 2002;86(7):1188-96.
• Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med. 1997;157(8):913-19.
• Shen T, Shi J, Wang N, Yu X, Zhang C, Li J, et al. 15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2015;309(5):L449-62.
• Sifre J, Alio JL, Ruiz IM, Ruiz O, Bellot JL. The antiinflammatory effect of nordihydroguaiaretic acid in endotoxin induced uveitis in rabbits. Ocul Immunol Inflamm. 1993;1(4):337-42.
• Simons FER, Ardusso LRF, Bilò MB, El-Gamal YA, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13-37.
• Soares SE. Phenolic acids as antioxidants. Rev Nutr. 2002;15(1):71-81.
• Spindler SR, Mote PL, Lublin AL, Flegal JM, Dhahbi JM, Li R. Nordihydroguaiaretic acid extends the lifespan of drosophila and mice, increases mortality-related tumors and hemorrhagic diathesis, and alters energy homeostasis in mice. J Gerontol A Biol Sci Med Sci. 2015;70(12):1479-89.
• Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 1993;62:797-82.
• Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Antiviral Res. 2014;109:132-40.
• Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7(5):641-50.
• Takekoshi S, Nagata H, Kitatani K. Stimulation of melanogenesis by nordihydroguaiaretic acid in human melanoma cells. Acta Histochem Cytochem. 2014;47(5):203-10.
• West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, et al. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor a activation of microglia and extends survival of G93A- SOD1 transgenic mice. J Neurochem. 2004;91(1):133-43.
• Yam-Canul P, Chirino YI, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, Villanueva C, et al. Nordihydroguaiaretic acid attenuates potassium dichromate-induced oxidative stress and nephrotoxicity. Food Chem Toxicol . 2008;46(3):1089-96.
• Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, Dhananjaya BL, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016;40-41:48-81.
• Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, et al. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat. 2005;94(1):37-46.
• Zhang H, Shen WJ, Li Y, Bittner A, Bittner S, Tabassum J, et al. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond). 2016;13:1-26.
• Zúñiga-Toalá1 A, Tapia E, Zazueta C, Correa F, Zataraín- Barrón ZL, Hernández-Pando R, et al. Nordihydroguaiaretic acid pretreatment prevents ischemia and reperfusion induced renal injury, oxidant stress and mitochondrial alterations. J Med Plant Res. 2012;6(12):2938-47.

Publication Dates

• Publication in this collection
  24 June 2022
• Date of issue
  2022

History

• Received
  22 July 2019
• Accepted
  23 Apr 2020